Moreover, higher TKTL1 expression levels were significantly associated with a better prognosis in early-stage kidney cancer (Stage 1 (OS HR = 0.45, p = 0.0072)) patients, whereas this association was not evident in the late stage (Table 1). This evidence concerns the gene TKTL1 and kidney cancer.